Clinical Trial Update: A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria [Phase 4]

View source ↗

Summary

Phase 4 crossover trial evaluating Hexalacton in patients with Type 1 diabetes mellitus and diabetic nephropathy; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Type 1 Diabetes Mellitus

Drugs mentioned

• Hexalacton

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetes Mellitus, Nephropathy | Phase 4 | Status: UNKNOWN